These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin. Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394 [TBL] [Abstract][Full Text] [Related]
24. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector. Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529 [TBL] [Abstract][Full Text] [Related]
25. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure. Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors. Li ML; Ren YJ; Dong MH; Ren WX Eur J Med Chem; 2015; 96():122-38. PubMed ID: 25874337 [TBL] [Abstract][Full Text] [Related]
27. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature. Liu JT; Paul W; Emerson M; Cicala C; Page CP Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481 [TBL] [Abstract][Full Text] [Related]
28. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors. Rupin A; Mennecier P; de Nanteuil G; Laubie M; Verbeuren TJ Thromb Res; 1995 May; 78(3):217-25. PubMed ID: 7631302 [TBL] [Abstract][Full Text] [Related]
29. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor. Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988 [TBL] [Abstract][Full Text] [Related]
30. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting. Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the anticoagulant activities of thrombin inhibitors as assessed by thromboelastographic analysis. Callas D; Iqbal O; Fareed J Semin Thromb Hemost; 1995; 21 Suppl 4():76-9. PubMed ID: 8747693 [No Abstract] [Full Text] [Related]
32. Selectivity enhancement induced by substitution of non-natural analogues of arginine and lysine in arginine-based thrombin inhibitors. Kokko KP; Arrigoni CE; Dix TA Bioorg Med Chem Lett; 2001 Jul; 11(14):1947-50. PubMed ID: 11459667 [TBL] [Abstract][Full Text] [Related]
33. The synthesis of arginylfluoroalkanes, their inhibition of trypsin and blood-coagulation serine proteinases and their anticoagulant activity. Ueda T; Kam CM; Powers JC Biochem J; 1990 Jan; 265(2):539-45. PubMed ID: 2302184 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity. Žula A; Będziak I; Kikelj D; Ilaš J Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine. Salvagnini C; Gharbi S; Boxus T; Marchand-Brynaert J Eur J Med Chem; 2007 Jan; 42(1):37-53. PubMed ID: 17010480 [TBL] [Abstract][Full Text] [Related]
36. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres. St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986 [TBL] [Abstract][Full Text] [Related]
37. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions. Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571 [TBL] [Abstract][Full Text] [Related]
38. Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting. Kawasaki K; Miyano M; Hirase K; Iwamoto M Chem Pharm Bull (Tokyo); 1993 May; 41(5):975-7. PubMed ID: 8339344 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors. Rewinkel JB; Lucas H; Smit MJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA Bioorg Med Chem Lett; 1999 Oct; 9(19):2837-42. PubMed ID: 10522702 [TBL] [Abstract][Full Text] [Related]
40. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide. Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]